Biogen Total Liabilities vs Net Income Common Stock Analysis

BIIB Stock  USD 215.63  0.71  0.33%   
Trend analysis of Biogen Inc balance sheet accounts such as Short Long Term Debt Total of 7.7 B, Other Current Liabilities of 969.8 M or Total Current Liabilities of 3.6 B provides information on Biogen's total assets, liabilities, and equity, which is the actual value of Biogen Inc to its prevalent stockholders. By breaking down trends over time using Biogen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

About Biogen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biogen Inc at a specified time, usually calculated after every quarter, six months, or one year. Biogen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biogen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biogen currently owns. An asset can also be divided into two categories, current and non-current.

Biogen Balance Sheet Chart

Biogen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biogen Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Biogen's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 7.7 B, whereas Cash is forecasted to decline to about 723.1 M.

Total Assets

Total assets refers to the total amount of Biogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biogen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biogen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 17.67, whereas Tax Provision is forecasted to decline to about 128.5 M.
 2021 2022 2023 2024 (projected)
Gross Profit8.9B7.9B7.3B3.9B
Total Revenue11.0B10.2B9.8B10.3B

Biogen fundamental ratios Correlations

0.920.670.950.940.960.850.990.630.99-0.570.610.97-0.740.940.56-0.820.960.860.930.590.89-0.80.3-0.80.39
0.920.630.860.760.890.960.90.580.9-0.720.590.85-0.620.980.54-0.920.970.80.870.450.83-0.630.33-0.630.29
0.670.630.780.530.640.460.630.790.58-0.430.880.59-0.670.690.45-0.640.730.240.79-0.10.73-0.560.74-0.560.44
0.950.860.780.850.920.750.910.720.92-0.530.670.88-0.740.890.45-0.790.940.750.90.430.94-0.740.34-0.740.52
0.940.760.530.850.890.680.940.560.93-0.370.520.95-0.730.780.54-0.630.820.860.870.70.79-0.850.18-0.850.29
0.960.890.640.920.890.820.920.590.96-0.50.540.95-0.780.920.56-0.750.940.880.870.50.95-0.780.21-0.780.44
0.850.960.460.750.680.820.830.330.86-0.70.380.78-0.50.940.48-0.860.910.810.730.540.71-0.560.22-0.560.22
0.990.90.630.910.940.920.830.630.97-0.620.60.97-0.660.920.51-0.850.940.850.930.610.83-0.730.28-0.730.33
0.630.580.790.720.560.590.330.630.51-0.410.90.59-0.640.590.42-0.60.640.30.83-0.070.72-0.470.52-0.470.34
0.990.90.580.920.930.960.860.970.51-0.550.490.96-0.690.930.52-0.780.950.910.860.670.86-0.780.18-0.780.4
-0.57-0.72-0.43-0.53-0.37-0.5-0.7-0.62-0.41-0.55-0.38-0.520.14-0.72-0.20.87-0.68-0.46-0.55-0.26-0.470.06-0.20.06-0.18
0.610.590.880.670.520.540.380.60.90.49-0.380.53-0.60.610.53-0.60.640.180.84-0.140.62-0.550.83-0.550.37
0.970.850.590.880.950.950.780.970.590.96-0.520.53-0.710.880.52-0.770.90.880.890.60.85-0.750.18-0.750.32
-0.74-0.62-0.67-0.74-0.73-0.78-0.5-0.66-0.64-0.690.14-0.6-0.71-0.64-0.570.42-0.68-0.56-0.75-0.26-0.80.85-0.360.85-0.28
0.940.980.690.890.780.920.940.920.590.93-0.720.610.88-0.640.55-0.920.990.790.880.430.85-0.650.37-0.650.39
0.560.540.450.450.540.560.480.510.420.52-0.20.530.52-0.570.55-0.330.530.430.60.190.51-0.650.43-0.650.05
-0.82-0.92-0.64-0.79-0.63-0.75-0.86-0.85-0.6-0.780.87-0.6-0.770.42-0.92-0.33-0.9-0.64-0.81-0.32-0.710.37-0.370.37-0.33
0.960.970.730.940.820.940.910.940.640.95-0.680.640.9-0.680.990.53-0.90.790.910.440.89-0.690.37-0.690.44
0.860.80.240.750.860.880.810.850.30.91-0.460.180.88-0.560.790.43-0.640.790.670.780.76-0.65-0.17-0.650.25
0.930.870.790.90.870.870.730.930.830.86-0.550.840.89-0.750.880.6-0.810.910.670.350.85-0.760.53-0.760.33
0.590.45-0.10.430.70.50.540.61-0.070.67-0.26-0.140.6-0.260.430.19-0.320.440.780.350.32-0.53-0.35-0.53-0.08
0.890.830.730.940.790.950.710.830.720.86-0.470.620.85-0.80.850.51-0.710.890.760.850.32-0.710.25-0.710.5
-0.8-0.63-0.56-0.74-0.85-0.78-0.56-0.73-0.47-0.780.06-0.55-0.750.85-0.65-0.650.37-0.69-0.65-0.76-0.53-0.71-0.361.0-0.22
0.30.330.740.340.180.210.220.280.520.18-0.20.830.18-0.360.370.43-0.370.37-0.170.53-0.350.25-0.36-0.360.29
-0.8-0.63-0.56-0.74-0.85-0.78-0.56-0.73-0.47-0.780.06-0.55-0.750.85-0.65-0.650.37-0.69-0.65-0.76-0.53-0.711.0-0.36-0.22
0.390.290.440.520.290.440.220.330.340.4-0.180.370.32-0.280.390.05-0.330.440.250.33-0.080.5-0.220.29-0.22
Click cells to compare fundamentals

Biogen Account Relationship Matchups

Biogen fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets27.2B24.6B23.9B24.6B26.8B28.2B
Short Long Term Debt Total6.4B7.8B7.6B6.6B7.3B7.7B
Other Current Liab3.4B3.3B3.3B2.8B838.4M969.8M
Total Current Liabilities4.9B3.7B4.3B3.3B3.4B3.6B
Total Stockholder Equity13.3B10.7B11.0B13.4B14.8B15.5B
Property Plant And Equipment Net3.7B3.8B3.8B3.7B3.7B3.9B
Net Debt3.5B6.5B5.3B3.2B6.3B6.6B
Retained Earnings16.5B14.0B13.9B16.5B17.6B18.5B
Cash2.9B1.3B2.3B3.4B1.0B723.1M
Non Current Assets Total18.9B17.7B16.0B14.8B20.0B21.0B
Non Currrent Assets Other(3.2B)(1.4B)1.9B1.5B284.3M270.1M
Cash And Short Term Investments4.5B2.6B3.8B4.9B1.0B1.5B
Net Receivables1.9B1.9B1.5B2.1B2.1B2.2B
Common Stock Shares Outstanding187.4M161.3M149.6M146M145.6M283.0M
Liabilities And Stockholders Equity27.2B24.6B23.9B24.6B26.8B28.2B
Non Current Liabilities Total9.0B10.2B8.6B7.9B8.6B9.0B
Other Current Assets1.2B1.3B1.2B1.4B1.2B1.2B
Other Stockholder Equity(3.0B)(3.0B)(2.8B)(2.9B)(2.7B)(2.5B)
Total Liab13.9B13.9B12.9B11.2B12.0B12.6B
Property Plant And Equipment Gross3.7B3.8B3.8B3.7B6.1B6.4B
Total Current Assets8.4B6.9B7.9B9.8B6.9B7.2B
Accumulated Other Comprehensive Income(135.2M)(299M)(106.7M)(164.9M)(153.7M)(146.0M)
Intangible Assets3.5B3.1B2.2B1.9B8.4B8.8B
Accounts Payable530.8M454.9M589.2M491.5M403.3M423.5M
Short Term Investments2.3B1.6B1.3B1.5B1.5B0.0
Inventory804.2M1.1B1.4B1.3B2.5B2.7B
Other Liab4.2B2.4B2.0B1.3B1.5B969.6M
Other Assets3.2B4.2B3.4B1.7B1.9B2.0B
Long Term Debt4.5B7.4B6.3B6.3B6.8B7.1B
Property Plant Equipment3.2B3.4B3.4B3.3B3.8B2.1B
Good Will5.8B5.8B5.8B5.7B6.2B3.2B
Net Tangible Assets4.1B1.9B2.9B5.8B6.7B4.1B
Noncontrolling Interest In Consolidated Entity(4.1M)(14.2M)63.5M(9.5M)(8.6M)(8.1M)
Retained Earnings Total Equity16.5B14.0B13.9B16.5B18.9B11.5B

Pair Trading with Biogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biogen Stock

  0.8MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Biogen Stock

  0.92EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.9DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.81MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.81MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.77TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.55)
Earnings Share
7.96
Revenue Per Share
67.972
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0458
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.